Berkshire Hathaway Inc. vs Merck & Co. Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Berkshire Hathaway Inc. (BRK-B) carries a "Neutral" signal with +0.7% revenue growth, while Merck & Co. Inc. (MRK) is "Neutral" with -2.2% revenue growth. Both companies report in the Financials and Healthcare sectors.
| Metric | Berkshire Hathaway Inc. (BRK-B) | Merck & Co. Inc. (MRK) |
|---|---|---|
| Operator Signal | Neutral | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $93.7B | $16.3B |
| Revenue Growth | 0.7%* | -2.2% |
| Latest EPS | N/A | $-1.72 |
| EPS Growth | N/A | -238.7% |
| Sector | Financials | Healthcare |
| Quarters Tracked | 8 | 8 |
Berkshire Hathaway Inc. (BRK-B) carries a "Neutral" signal with +0.7% revenue growth, while Merck & Co. Inc. (MRK) is "Neutral" with -2.2% revenue growth. Both companies report in the Financials and Healthcare sectors.